Background Schizophrenia (SZ), a complex and chronic neuropsychiatric disorder affecting
approximately 1% of the general population, presents diagnostic challenges due to the …

MicroRNAs (miRNA, miR) have been implicated as promising blood‐based biomarkers for
schizophrenia patients. This study aimed to clinically validate miRNA as potential …

There is an increasing interest in searching biomarkers for schizophrenia (SZ) diagnosis,
which overcomes the drawbacks inherent with the subjective diagnostic methods. MicroRNA …

Findings from multiple studies on microRNA (miRNA) expression profiling in schizophrenia
patients have produced conflicting results. In order to investigate miRNA as specific …

MicroRNAs (miRNAs) are a class of endogenous and non-coding single-stranded RNAs
with length of about 22 nucleotides, and many are evolutionarily conserved. Although …

Background The development of schizophrenia is related to a combination of genetic and
epigenomic factors. MicroRNAs (miRNAs) play a crucial role in epigenetic processes and …

Based on our previous finding of a seven-miRNA (hsa-miR-34a, miR-449a, miR-564, miR-
432, miR-548d, miR-572 and miR-652) signature as a potential biomarker for schizophrenia …

Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to
demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to …

Alterations in microRNAs (miRNAs) have been considered to have diagnostic implications in
most diseases, but few studies have reported dysregulated miRNAs in schizophrenia (SCZ) …

A bstract Background At present, the schizophrenia diagnoses are based on the clinical
symptoms and behaviors neglecting the laboratory test indicators. Results To better …